FDA Import Refusal AEK-9160794-3/10003/1 — GLAXOSMITHKLINE PHARMACEUTICALS
The FDA refused shipment AEK-9160794-3/10003/1 from GLAXOSMITHKLINE PHARMACEUTICALS (India) on Jan 18, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 18, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LDA01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 75